【沛嘉医疗-B(09996.HK):国家药监局批准Syphonet®取栓支架注册申请】智通财经APP讯,沛嘉医疗-B(09996.HK)发布公告,于2022年2月11日,集团收到国家药品监督管理局对Syphonet®取栓支架(先前英文名为Shenyi®)注册申请的批准,使其成为集团第11个获国家药监局批准的神经介入产品。
Share
Listen to the news
【沛嘉医疗-B(09996.HK):国家药监局批准Syphonet®取栓支架注册申请】智通财经APP讯,沛嘉医疗-B(09996.HK)发布公告,于2022年2月11日,集团收到国家药品监督管理局对Syphonet®取栓支架(先前英文名为Shenyi®)注册申请的批准,使其成为集团第11个获国家药监局批准的神经介入产品。
【沛嘉医疗-B(09996.HK):国家药监局批准Syphonet®取栓支架注册申请】智通财经APP讯,沛嘉医疗-B(09996.HK)发布公告,于2022年2月11日,集团收到国家药品监督管理局对Syphonet®取栓支架(先前英文名为Shenyi®)注册申请的批准,使其成为集团第11个获国家药监局批准的神经介入产品。
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
avatar
Share your ideas here…

All Comments

What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.